Evolution of a Unified Strategy for Complex Sesterterpenoids: Progress toward Astellatol and the Total Synthesis of (−)-Nitidasin

Astellatol and nitidasin belong to a subset of sesterterpenoids that share a sterically encumbered trans‐hydrindane motif with an isopropyl substituent. In addition, these natural products feature intriguing polycyclic ring systems, posing significant challenges for chemical synthesis. Herein, the e...

Full description

Saved in:
Bibliographic Details
Published inChemistry : a European journal Vol. 21; no. 39; pp. 13646 - 13665
Main Authors Hog, Daniel T., Huber, Florian M. E., Jiménez-Osés, Gonzalo, Mayer, Peter, Houk, Kendall N., Trauner, Dirk
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 21.09.2015
WILEY‐VCH Verlag
Wiley
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Astellatol and nitidasin belong to a subset of sesterterpenoids that share a sterically encumbered trans‐hydrindane motif with an isopropyl substituent. In addition, these natural products feature intriguing polycyclic ring systems, posing significant challenges for chemical synthesis. Herein, the evolution of our stereoselective strategy for isopropyl trans‐hydrindane sesterterpenoids is detailed. These endeavors included the synthesis of several building blocks, enabling studies toward all molecules of this terpenoid subclass, and of advanced intermediates of our initial route toward a biomimetic synthesis of astellatol. These findings provided the basis for a second‐generation and a third‐generation approach toward astellatol that eventually culminated in the enantioselective total synthesis of (−)‐nitidasin. In particular, a series of substrate‐controlled transformations to install the ten stereogenic centers of the target molecule was orchestrated and the carbocyclic backbone was forged in a convergent fashion. Furthermore, the progress toward the synthesis of astellatol is disclosed and insights into some observed yet unexpected diastereoselectivities by detailed quantum‐mechanical calculations are provided. Two and a half molecules: Astellatol and nitidasin are polycyclic sesterterpenoids, posing considerable challenges for synthetic chemists. In this full account, the evolution of a synthetic strategy for these and structurally related natural products is given (see scheme). The presented work includes efforts toward a biomimetic synthesis of astellatol, a successful route for the first total synthesis of (−)‐nitidasin, and quantum‐mechanical investigations into unexpected diastereosectivities.
Bibliography:National Science Foundation - No. OCI-1053575
ArticleID:CHEM201501423
Fonds der Chemischen Industrie
istex:81E26CCF613D9AF723127958587933664200B791
ark:/67375/WNG-K58P1XFN-9
Deutsche Forschungsgemeinschaft - No. SFB 749
NIH-NIGMS - No. GM075962
UCLA Institute of Digital Research and Education (IDRE)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Dedicated to Prof. Wolfgang Steglich
Present address: Bayer Health Care, Bayer Pharma AG BPH-GDD-CGEI-MCB-MCII, Müllerstr. 178, 13353 Berlin, Germany.
ISSN:0947-6539
1521-3765
DOI:10.1002/chem.201501423